Mitochondial DNA damage, potential target to reduce the development of renal disorders induced by maternal smoking .

Unfortunately, this opportunity is currently unavailable. Please check back at a later date.

Summary

Smoking rates are disproportionately high in disadvantaged populations, particularly in emerging economies, and increasing in women of child bearing age.

Supervisor(s)

Dr Sonia Saad

Research Location

North Shore - Kolling Institute of Medical Research

Program Type

Masters/PHD

Synopsis

Epidemiological studies have shown that maternal smoking is associated with a number of adverse fetal outcomes including intrauterine growth retardation and increased risk of obesity, hypertension, chronic kidney disease (CKD) and type 2 diabetes later in life. We hypothesize that maternal smoking leads to oxidative stress and fetal epigenetic mitochondrial DNA mutations resulting in intrauterine growth retardation and predisposition to chronic kidney disease (CKD). A mouse model will be used to address this hypothesis. Interventions will be tested in both pregnant mothers and offspring changes with the aim being to prevent future renal dysfunction. The project will address two of the national health strategic initiatives which focus on a healthy start to life and chronic disease and its impact on the Australian health burden. We anticipate that our outcome will be highly relevant for the prevention of CKD in offspring from smoking mothers and will also have a potential for therapeutic interventions that will translate into clinical practice.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD. Domestic students and International students

Browse for other opportunities within the North Shore - Kolling Institute of Medical Research .

Keywords

smoking, Pregnancy, Obesity, Hypertension, chronic kidney disease, Type 2 diabetes

Opportunity ID

The opportunity ID for this research opportunity is: 1557

Other opportunities with Dr Sonia Saad